QCM
BIO icon

Quantinno Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantinno Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81M Sell
30,004
-3,646
-11% -$1.03M 0.01% 1034
2026
Q1 		$9.38M Sell
33,650
-2,585
-7% -$744K 0.02% 894
2025
Q4 		$11M Buy
36,235
+8,447
+30% +$2.64M 0.02% 747
2025
Q3 		$7.79M Buy
27,788
+22,879
+466% +$6.23M 0.02% 764
2025
Q2 		$1.18M Buy
4,909
+2,907
+145% +$687K 0.01% 1261
2025
Q1 		$488K Sell
2,002
-5,848
-74% -$1.76M ﹤0.01% 1390
2024
Q4 		$2.58M Buy
7,850
+6,646
+552% +$2.26M 0.03% 756
2024
Q3 		$403K Buy
+1,204
New +$382K 0.01% 1184
2024
Q2 		– Sell
-4,152
Closed -$1.44M – 1318
2024
Q1 		$1.44M Buy
4,152
+1,822
+78% +$599K 0.03% 637
2023
Q4 		$752K Buy
2,330
+674
+41% +$211K 0.03% 706
2023
Q3 		$594K Buy
+1,656
New +$639K 0.03% 677
2023
Q2 		– Sell
-2,136
Closed -$1.02M – 904
2023
Q1 		$1.02M Buy
2,136
+1,385
+184% +$648K 0.07% 374
2022
Q4 		$316K Buy
+751
New +$303K 0.02% 671
2022
Q2 		– Sell
-593
Closed -$334K – 609
2022
Q1 		$334K Buy
+593
New +$357K 0.05% 412
2021
Q4 		– Sell
-317
Closed -$236K – 503
2021
Q3 		$236K Buy
+317
New +$237K 0.26% 194
2020
Q1 		– Sell
-856
Closed -$317K – 380
2019
Q4 		$317K Buy
+856
New +$302K 0.2% 243

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Quantinno Capital Management's BIO Position: Q2 2026 in Review

Quantinno Capital Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 11% in Q2 2026, selling an estimated $1.03M and leaving 30,004 shares worth $8.81M. The position accounts for 0.01% of the portfolio, ranked #1034.

Quantinno Capital Management first reported a position in BIO in Q4 2019 and has held it in 16 quarters since. The position peaked at $11M in Q4 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Quantinno Capital Management held 30,004 shares of Bio-Rad Laboratories Class A worth $8.81M as of Q2 2026.
  • Quantinno Capital Management sold 3,646 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.03M.
  • Bio-Rad Laboratories Class A made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1034 holding.
  • Quantinno Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 16 quarters since.
  • Quantinno Capital Management's Bio-Rad Laboratories Class A position peaked at $11M in Q4 2025.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.